JHP Pharmaceuticals to Produce Lyophilized Biologic for Late-Phase Trials

JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products, has entered into an agreement with an undisclosed pharmaceutical company to produce supplies of a lyophilized biologic for international, late-phase clinical trials.
Stuart Hinchen president and CEO of JHP stated, "We know that customers want to seamlessly progress from clinical batch production to product launch and then commercialization.  JHP's established infrastructure and expertise transitioning products

Labeling Error Spurs Recall of Baxter Biologic

Baxter Healthcare Corp. has recalled vials of GAMMAGARD LIQUID 10%, 20g, due to incorrect manufacturing and expiration dates.

GAMMAGARD LIQUID, [Immune Globulin Intravenous (Human)] 10%, 20g size
Product Code 1502797
NDC # 0944-2700-06
Baxter Healthcare Corp.
Westlake Village, CA

No votes yet
Syndicate content